Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)
Abstract
:1. Background of BRONJ
2. Characteristics of the Oral Mucosa
3. Impact of Bisphosphonate on Fibroblasts
4. Impact of Bisphosphonates on Keratinocytes
5. Bisphosphonates Influence Oral Wound Healing
6. Summary
Author Contributions
Conflicts of Interest
References
- Marx, R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J. Oral Maxillofac. Surg. 2003, 61, 1115–1117. [Google Scholar] [CrossRef]
- Stumpe, M.R.; Chandra, R.K.; Yunus, F.; Samant, S. Incidence and risk factors of bisphosphonate-associated osteonecrosis of the jaws. Head Neck 2009, 31, 202–206. [Google Scholar] [CrossRef] [PubMed]
- Walter, C.; Al-Nawas, B.; Grotz, K.A.; Thomas, C.; Thuroff, J.W.; Zinser, V.; Gamm, H.; Beck, J.; Wagner, W. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur. Urol. 2008, 54, 1066–1072. [Google Scholar] [CrossRef] [PubMed]
- Crincoli, V.; Ballini, A.; Di Comite, M.; Tettamanti, L.; Coscia, M.F.; Mastrangelo, F.; De Vito, D. Microbiological investigation of medication-related osteonecrosis of the jaw: Preliminary results. J. Biol. Regul. Homeost. Agents 2015, 29, 977–983. [Google Scholar] [PubMed]
- Hoefert, S.; Sade Hoefert, C.; Munz, A.; Schmitz, I.; Grimm, M.; Yuan, A.; Northoff, H.; Reinert, S.; Alexander, D. Effect of bisphosphonates on macrophagic THP-1 cell survival in bisphosphonate-related osteonecrosis of the jaw (BRONJ). Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2016, 121, 222–232. [Google Scholar] [CrossRef] [PubMed]
- Yang, H.; Pan, H.; Yu, F.; Chen, K.; Shang, G.; Xu, Y. A novel model of bisphosphonate-related osteonecrosis of the jaw in rats. Int. J. Clin. Exp. Pathol. 2015, 8, 5161–5167. [Google Scholar] [PubMed]
- Huang, Y.F.; Chang, C.T.; Muo, C.H.; Tsai, C.H.; Shen, Y.F.; Wu, C.Z. Impact of bisphosphonate-related osteonecrosis of the jaw on osteoporotic patients after dental extraction: A population-based cohort study. PLoS ONE 2015, 10, e0120756. [Google Scholar] [CrossRef] [PubMed]
- Sun, J.; Wen, X.; Jin, F.; Li, Y.; Hu, J.; Sun, Y. Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma. Onco Targets Ther. 2015, 8, 2681–2688. [Google Scholar] [CrossRef] [PubMed]
- Hoefert, S.; Sade Hoefert, C.; Munz, A.; Northoff, H.; Yuan, A.; Reichenmiller, K.; Reinert, S.; Grimm, M. Altered macrophagic THP-1 cell phagocytosis and migration in bisphosphonate-related osteonecrosis of the jaw (BRONJ). Clin. Oral Investig. 2016, 20, 1043–1054. [Google Scholar] [CrossRef] [PubMed]
- Rosella, D.; Papi, P.; Giardino, R.; Cicalini, E.; Piccoli, L.; Pompa, G. Medication-related osteonecrosis of the jaw: Clinical and practical guidelines. J. Int. Soc. Prev. Community Dent. 2016, 6, 97–104. [Google Scholar] [PubMed]
- Walter, C.; Pabst, A.M.; Ziebart, T. Effects of a low-level diode laser on oral keratinocytes, oral fibroblasts, endothelial cells and osteoblasts incubated with bisphosphonates: An in vitro study. Biomed. Rep. 2015, 3, 14–18. [Google Scholar] [CrossRef] [PubMed]
- Deckers, M.M.; Van Beek, E.R.; Van Der Pluijm, G.; Wetterwald, A.; Van Der Wee-Pals, L.; Cecchini, M.G.; Papapoulos, S.E.; Löwik, C.W.G.M. Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice. J. Bone Miner. Res. 2002, 17, 998–1007. [Google Scholar] [CrossRef] [PubMed]
- Otto, S.; Schreyer, C.; Hafner, S.; Mast, G.; Ehrenfeld, M.; Sturzenbaum, S.; Pautke, C. Bisphosphonate-related osteonecrosis of the jaws—Characteristics, risk factors, clinical features, localization and impact on oncological treatment. J. Craniomaxillofac. Surg. 2012, 40, 303–309. [Google Scholar] [CrossRef] [PubMed]
- Mozzati, M.; Arata, V.; Gallesio, G. Tooth extraction in osteoporotic patients taking oral bisphosphonates. Osteoporos. Int. 2013, 24, 1707–1712. [Google Scholar] [CrossRef] [PubMed]
- Mucke, T.; Koerdt, S.; Jung, M.; Mitchell, D.A.; Wolff, K.D.; Kesting, M.R.; Loeffelbein, D.J. The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws. J. Craniomaxillofac. Surg. 2016, 44, 369–373. [Google Scholar] [CrossRef] [PubMed]
- Mucke, T.; Jung, M.; Koerdt, S.; Mitchell, D.A.; Loeffelbein, D.; Kesting, M.R. Free flap reconstruction for patients with bisphosphonate related osteonecrosis of the jaws after mandibulectomy. J. Craniomaxillofac. Surg. 2016, 44, 142–147. [Google Scholar] [CrossRef] [PubMed]
- Bae, S.; Sun, S.; Aghaloo, T.; Oh, J.E.; McKenna, C.E.; Kang, M.K.; Shin, K.H.; Tetradis, S.; Park, N.H.; Kim, R.H. Development of oral osteomucosal tissue constructs in vitro and localization of fluorescently-labeled bisphosphonates to hard and soft tissue. Int. J. Mol. Med. 2014, 34, 559–563. [Google Scholar] [CrossRef] [PubMed]
- Kuiper, J.W.; Forster, C.; Sun, C.; Peel, S.; Glogauer, M. Zoledronate and pamidronate depress neutrophil functions and survival in mice. Br. J. Pharmacol. 2012, 165, 532–539. [Google Scholar] [CrossRef] [PubMed]
- Hagelauer, N.; Pabst, A.M.; Ziebart, T.; Ulbrich, H.; Walter, C. In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes. Clin. Oral Investig. 2015, 19, 139–148. [Google Scholar] [CrossRef] [PubMed]
- Odvina, C.V.; Zerwekh, J.E.; Rao, D.S.; Maalouf, N.; Gottschalk, F.A.; Pak, C.Y. Severely suppressed bone turnover: A potential complication of alendronate therapy. J. Clin. Endocrinol. Metab. 2005, 90, 1294–1301. [Google Scholar] [CrossRef] [PubMed]
- Kong, Y.Y.; Yoshida, H.; Sarosi, I.; Tan, H.L.; Timms, E.; Capparelli, C.; Morony, S.; Oliveira-dos-Santos, A.J.; Van, G.; Itie, A.; et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397, 315–323. [Google Scholar] [PubMed]
- Giuliani, N.; Pedrazzoni, M.; Passeri, G.; Girasole, G. Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Scand. J. Rheumatol. 1998, 27, 38–41. [Google Scholar] [PubMed]
- Tipton, D.A.; Seshul, B.A.; Dabbous, M. Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. J. Periodontal Res. 2011, 46, 39–47. [Google Scholar] [CrossRef] [PubMed]
- Krajewski, A.C.; Biessei, J.; Kunze, M.; Maersch, S.; Perabo, L.; Noack, M.J. Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells. APMIS 2009, 117, 746–754. [Google Scholar] [CrossRef] [PubMed]
- Boyle, W.J.; Simonet, W.S.; Lacey, D.L. Osteoclast differentiation and activation. Nature 2003, 423, 337–342. [Google Scholar] [CrossRef] [PubMed]
- Pabst, A.M.; Ziebart, T.; Koch, F.P.; Taylor, K.Y.; Al-Nawas, B.; Walter, C. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes—In vitro study. Clin. Oral Investig. 2012, 16, 87–93. [Google Scholar] [CrossRef] [PubMed]
- Wang, K.; Yamamoto, H.; Chin, J.R.; Werb, Z.; Vu, T.H. Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J. Biol. Chem. 2004, 279, 53848–53856. [Google Scholar] [CrossRef] [PubMed]
- Yan, T.; Riggs, B.; Boyle, W.; Khosla, S. Regulation of osteoclastogenesis and RANK expression by TGF-β1. J. Cell. Biochem. 2001, 83, 320–325. [Google Scholar] [CrossRef] [PubMed]
- Zandi, M.; Dehghan, A.; Ghadermazi, K.; Malekzadeh, H.; Akbarzadeh, M. Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats. J. Cranio-Maxillofac. Surg. 2015, 43, 1823–1828. [Google Scholar] [CrossRef] [PubMed]
- Wallace, J.; Dicay, M.; McKnight, W.; Bastaki, S.; Blank, M. N-bisphosphonates cause gastric epithelial injury independent of effects on the microcirculation. Aliment. Pharmacol. Ther. 1999, 13, 1675–1682. [Google Scholar] [CrossRef] [PubMed]
- Landesberg, R.; Cozin, M.; Cremers, S.; Woo, V.; Kousteni, S.; Sinha, S.; Garrett-Sinha, L.; Raghavan, S. Inhibition of oral mucosal cell wound healing by bisphosphonates. J. Oral Maxillofac. Surg. 2008, 66, 839–847. [Google Scholar] [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ziebart, T.; Halling, F.; Heymann, P.; Neff, A.; Blatt, S.; Jung, J.; Pabst, A.; Righesso, L.; Walter, C. Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ). Dent. J. 2016, 4, 36. https://doi.org/10.3390/dj4040036
Ziebart T, Halling F, Heymann P, Neff A, Blatt S, Jung J, Pabst A, Righesso L, Walter C. Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ). Dentistry Journal. 2016; 4(4):36. https://doi.org/10.3390/dj4040036
Chicago/Turabian StyleZiebart, Thomas, Frank Halling, Paul Heymann, Andreas Neff, Sebastian Blatt, Junho Jung, Andreas Pabst, Leonardo Righesso, and Christian Walter. 2016. "Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)" Dentistry Journal 4, no. 4: 36. https://doi.org/10.3390/dj4040036